Stock Signals
A 0 to 100 Signal Score that flags unusual volume, momentum and 52-week activity to surface names worth a closer look. Not advice, not a prediction, and not yet backtested. Always do your own research. How scoring works →
0 high-signal · hourly
⚠️ Read this: a high score means a stock is showing unusual activity right now. It is not a buy recommendation and is not a forecast of future gains. The scoring model has no published track record yet. Treat this as a starting point for research, never a reason to trade.
🚨 Get BUY-signal alerts
Free email the moment a stock crosses a 75+ Signal Score. No spam, unsubscribe anytime.
AllSemiconductorsAI & SoftwareBiotechEnergyEV & CleanFintechSpace & DefenseMaterialsIndustrialsConsumer
| # | Stock⇅ | Score▼ | Price⇅ | 1D⇅ | 1W⇅ | 1M⇅ | Mkt cap⇅ |
|---|---|---|---|---|---|---|---|
| 01 | LLY Eli Lilly and Co | 59 | $1,443.50 | +1.14% | +5.41% | +0.69% | $1.4T |
| 02 | TGTX TG Therapeutics Inc | 56 | $64.51 | -0.08% | +7.91% | +5.52% | $9.8B |
| 03 | REGN Regeneron Pharmaceuticals Inc | 46 | $955.47 | +0.45% | +5.18% | +2.51% | $98.8B |
| 04 | FOLD Amicus Therapeutics Inc | 40 | $14.49 | +0.00% | +0.21% | +0.21% | $4.5B |
| 05 | ABBV AbbVie Inc | 38 | $295.03 | +0.20% | +1.08% | +4.10% | $521.5B |
| 06 | BIIB Biogen Inc | 34 | $253.40 | +1.17% | +0.86% | -1.24% | $37.5B |
| 07 | EXEL Exelixis Inc | 31 | $69.00 | -1.20% | +0.39% | +0.65% | $16.8B |
| 08 | AMGN Amgen Inc | 28 | $465.67 | -0.30% | +1.44% | +0.23% | $251.9B |
| 09 | VRTX Vertex Pharmaceuticals Inc | 28 | $538.60 | -0.74% | -0.82% | -2.91% | $134B |
| 10 | MRK Merck & Co Inc | 22 | $147.76 | +0.55% | +0.15% | -1.72% | $364.3B |
| 11 | ALNY Alnylam Pharmaceuticals Inc | 19 | $165.04 | +5.36% | +0.46% | -5.06% | $22.1B |
| 12 | MRNA Moderna Inc | 15 | $223.37 | -3.45% | -8.99% | -5.55% | $90.4B |
| 13 | ACAD ACADIA Pharmaceuticals Inc | 15 | $18.75 | +3.36% | -14.55% | -11.90% | $3.2B |
| 14 | GILD Gilead Sciences, Inc | 14 | $168.08 | +0.08% | -0.73% | -1.52% | $208.5B |
| 15 | HALO Halozyme Therapeutics Inc | 13 | $100.27 | -0.40% | -2.86% | -23.10% | $11.4B |
| 16 | NVO Novo Nordisk A/S | 9 | $41.63 | +2.41% | +2.07% | +4.64% | $1.2T |
| 17 | VKTX Viking Therapeutics Inc | 6 | $29.22 | +5.95% | +0.79% | +7.11% | $3.7B |
| 18 | INSM Insmed Inc | 3 | $121.16 | +2.62% | +3.20% | +4.88% | $26.6B |
| 19 | RARE Ultragenyx Pharmaceutical Inc | 2 | $16.08 | -1.17% | +5.44% | +1.06% | $1.6B |
| 20 | PFE Pfizer Inc | 0 | $28.89 | +0.21% | -1.16% | -0.45% | $164.7B |
| 21 | RXRX Recursion Pharmaceuticals Inc | 0 | $3.19 | -4.35% | -5.40% | -17.37% | $2B |
| 22 | ARWR Arrowhead Pharmaceuticals Inc | 0 | $47.78 | +1.34% | -18.93% | -21.29% | $6.7B |
| 23 | IONS Ionis Pharmaceuticals Inc | 0 | $29.06 | +6.41% | -30.72% | -37.25% | $4.8B |
| 24 | BEAM Beam Therapeutics Inc | 0 | $22.83 | -4.99% | -9.01% | -11.75% | $2.4B |
| 25 | SRPT Sarepta Therapeutics Inc | 0 | $16.07 | +0.37% | -10.16% | -14.02% | $1.7B |
| 26 | NTLA Intellia Therapeutics Inc | 0 | $9.70 | -8.06% | -7.05% | -15.40% | $1.4B |
| 27 | DNA Ginkgo Bioworks Holdings Inc | 0 | $9.61 | -6.06% | -9.39% | -8.74% | $636.7M |
| 28 | BNTX Biontech SE | 0 | $85.60 | +0.66% | -2.82% | -3.55% | $21.1B |
| 29 | CRSP CRISPR Therapeutics AG | 0 | $42.24 | -0.89% | -14.88% | -17.11% | $4.1B |
| 30 | BMRN BioMarin Pharmaceutical Inc | 0 | $57.23 | +0.93% | +0.09% | -2.19% | $11.1B |